lovastatin has been researched along with Chronic Hepatitis C in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abdelaziz, A; Abdelgaied, MY; Abdelkawy, KS; Belal, F; El-Khodary, NM; Elmekawy, HA | 1 |
| Gibson, K; Rindone, JP | 1 |
1 trial(s) available for lovastatin and Chronic Hepatitis C
| Article | Year |
|---|---|
Statins Increase the Bioavailability of Fixed-Dose Combination of Sofosbuvir/Ledipasvir by Inhibition of P-glycoprotein.
Topics: Antiviral Agents; Atorvastatin; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; Benzimidazoles; Biological Availability; Cross-Over Studies; Drug Combinations; Fluorenes; Hepatitis C, Chronic; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Lovastatin; Sofosbuvir | 2022 |
1 other study(ies) available for lovastatin and Chronic Hepatitis C
| Article | Year |
|---|---|
Experience with statin use in patients with chronic hepatitis C infection.
Topics: Aged; Alanine Transaminase; Anticholesteremic Agents; Aspartate Aminotransferases; Biomarkers; Cholesterol; Hepatitis C, Chronic; Humans; Hypercholesterolemia; Lovastatin; Male; Middle Aged; Prevalence; Simvastatin; Treatment Outcome; United States | 2005 |